CFA
CASI

Carroll Financial Associates’s CASI Pharmaceuticals CASI Stock Holding History

Carroll Financial Associates’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1
Closed -$14 – 1079
2015
Q2 		$0 Buy
+1
New +$15 ﹤0.01% 1076
2014
Q4 		– Sell
-1
Closed – – 748
2014
Q3 		$0 Buy
+1
New +$18 ﹤0.01% 842
2014
Q2 		– Sell
-1
Closed – – 914
2014
Q1 		$0 Hold
1
– – ﹤0.01% 873
2013
Q4 		$0 Hold
1
– – ﹤0.01% 811
2013
Q3 		$0 Hold
1
– – ﹤0.01% 801
2013
Q2 		$0 Buy
+1
New +$19 ﹤0.01% 622

Other funds holding CASI

WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.57B AUM 37.84% 1-Year Est. Return
CWM
Concert Wealth Management San Jose, California $24.7M AUM 14.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Carroll Financial Associates's CASI Position: Q3 2015 in Review

Carroll Financial Associates sold out of CASI Pharmaceuticals (CASI) in Q3 2015, closing a stake of 1 share — an estimated $14 sold.

Carroll Financial Associates first reported a position in CASI in Q2 2013 and held it in 6 quarters. The position peaked at $0 in Q2 2015. 31 funds tracked by Wall St. Rank hold CASI as of Q3 2015.

  • Carroll Financial Associates reported no remaining CASI Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Carroll Financial Associates sold 1 CASI Pharmaceuticals share in Q3 2015, an estimated $14.
  • Carroll Financial Associates first reported a position in CASI Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • Carroll Financial Associates's CASI Pharmaceuticals position peaked at $0 in Q2 2015.
  • 31 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q3 2015.

Based on Carroll Financial Associates's 13F filing for Q3 2015, filed 28 Oct 2015.